Photocure Partner Asieris presented clinical trial and real-world data on Hexvix in China at ASCO GU 2024
Oslo, Norway, January 29, 2024: Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces that its partner Asieris presented Phase III Clinical Study and Real-World Research Data for Hexvix[®] (APL-1706) at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU), on Friday, January 26, 2024 in San Francisco.The poster presentation (Abstract No. 593) “Blue Light Cystoscopy versus White Light Cystoscopy for the Detection of Bladder Cancer in China: An Analysis of Unpublished Clinical Trial and Real-World Data.” included data from a recent randomized